- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06894589
Assessment of the Perceptions and Opinions of Staff Working of Prisons and Detention Centers on the Use of Psychoactive Substances in Prisons and Harm Reduction (PERRCEP) (PERRCEP)
Assessment of the Perceptions and Opinions of Staff Working in Prisons and Detention Centers on the Use of Psychoactive Substances in Prisons and Harm Reduction
Study Overview
Status
Conditions
Detailed Description
A first contact will be made by email with the heads of institutions, directors of Penitentiary Rentegration Services), and coordinating doctors of healthcare units to inform them about the study's objectives and procedures, and to request their institution's and service's participation.
If they agree to participate, volunteer key contacts will be identified in each institution to relay the information to the staff working in the institution and ensure the distribution of the questionnaire.
The study's responsible doctor will meet with one of the resident investigators for a preliminary informational meeting with the institution's director, the SPIP director, and the identified key staff members. The questionnaires will be handed to the key contacts at that time.
A "non-opposition" letter will be individually distributed with each anonymous questionnaire to provide further details about the study for which their participation is requested.
After answering, participants will be able to place the questionnaire in the provided envelope, and then into a sealed ballot box.
After the answering period, the investigator will go back to prisons and detention centers to collect the ballot boxes.
The data from each paper questionnaire will be transcribed by the residents onto an online platform using the Lime Survey® software.
The statistician of UBO (university of Brest) will have access to the data on Lime Survey® in order to perform the statistical analyses as described below.
The statistician will make a descriptive analysis of the results and the an analytical study will research factors associated with improved adherence to harm reduction mesures : profession exercised; seniority; harm reduction training; age
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
-
Brest, France, 29200
- CHU Brest
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Working person of remand center of Brest, Vannes, Rennes, Saint-Malo, Lorient and Saint-Brieuc, and detention center of Lorient and Rennes :
- healthcare staff, divided into 5 sectors : somatic, psychiatric, odontology, addictology, pharmacy)
- prison warders
- Reintegration support service (in french : Service pénitentiaire d'insertion et de probation)
- other prison staff
Description
Inclusion Criteria:
- working person of remand center of Brest, Vannes, Rennes, Saint-Malo, Lorient and Saint-Brieuc, who has answered the questionnaire
- working person of detention center of Lorient and Rennes, who answered the questionnaire
Exclusion Criteria:
- person opposing participation in the study
- person under legal protection measure
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
perceptions and opinions of staff working in prisons and detention centers in Brittany regarding the consumption of illicit substances and harm reduction measures.
Time Frame: from january 2025 to may 2025
|
descriptive analysis of the results
|
from january 2025 to may 2025
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assess training needs and research factors associated with improved adherence to harm reduction mesures
Time Frame: from january 2025 to may 2025
|
An analytical study will research factors associated with improved adherence to harm reduction mesures : profession exercised; seniority; harm reduction training; age.
|
from january 2025 to may 2025
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 29BRC24.0333 - PERRCEP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Harm Reduction
-
National Cheng Kung UniversityHealing, Empowerment, Recovery of Chemsex (HERO) integrated care clinicCompleted
-
University of PennsylvaniaCompleted
-
Rose Research Center, LLCFoundation for a Smoke Free World INCTerminatedSmoking Cessation | Harm ReductionUnited States
-
Contract Research Organization el ABSwedish Match ABCompletedSmoking Cessation | Harm ReductionSweden
-
Jacques GaumeSwiss National Science Foundation; Apptitude; Addiction SwitzerlandEnrolling by invitationCannabis Use | Harm ReductionSwitzerland
-
Rose Research Center, LLCFoundation for a Smoke-Free WorldCompletedSmoking Cessation | Harm ReductionUnited States
-
Far Eastern Memorial HospitalCompletedHarm Reduction | Adolescent BehaviorTaiwan
-
Contract Research Organization el ABSwedish Match ABCompletedSmoking Cessation | Harm Reduction | Smokeless TobaccoSweden
-
Contract Research Organization el ABSwedish Match ABCompletedSmoking Cessation | Harm Reduction | Smokeless TobaccoSweden
-
Rose Research Center, LLCGlobal Action to End SmokingCompletedSmoking Cessation | Harm ReductionUnited States